VAM
ITOS

Vazirani Asset Management’s iTeos Therapeutics ITOS Stock Holding History

Vazirani Asset Management’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-35,000
Closed -$349K – 20
2025
Q2 		$349K Buy
+35,000
New +$282K 1.33% 16

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vazirani Asset Management's ITOS Position: Q3 2025 in Review

Vazirani Asset Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 35,000 shares — an estimated $349K sold.

Vazirani Asset Management first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $349K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Vazirani Asset Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Vazirani Asset Management sold 35,000 iTeos Therapeutics shares in Q3 2025, an estimated $349K.
  • Vazirani Asset Management first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
  • Vazirani Asset Management's iTeos Therapeutics position peaked at $349K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Vazirani Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.